Ran Kong
No. 324, Jingwu Road
Jinan, 250021, China
Jinan, 250021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
In vivo CAR-T therapy: latest updates from the 2025 ASH annual meeting.
Journal: Biomarker research
Published: February 22, 2026
Dual-target CAR-T cell therapy: latest updates from the 2025 ASH annual meeting.
Journal: Experimental hematology & oncology
Published: February 21, 2026
Causal links between gut microbiota, metabolites, and diffuse large B-cell lymphoma: Evidence from a Mendelian randomization study.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: March 09, 2025
CAR-NK cell therapy: latest updates from the 2024 ASH annual meeting.
Journal: Journal of hematology & oncology
Published: January 10, 2025
A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells.
Journal: Leukemia
Published: January 09, 2025
Amino Acid Metabolism-Related Gene Kynureninase (KYNU) as a Prognostic Predictor and Regulator of Diffuse Large B-Cell Lymphoma.
Journal: Biochemical genetics
Published: October 17, 2024
Aberrant sialylation in cancer: From molecular mechanisms to potential therapeutics.
Journal: Genes & diseases
Published: September 23, 2024
Expression Profile and Prognostic Significance of Pivotal Regulators for N7-Methylguanosine Methylation in Diffuse Large B-Cell Lymphoma.
Journal: Molecular biotechnology
Published: July 07, 2024
Targeted protein degradation in hematologic malignancies: latest updates from the 2023 ASH annual meeting.
Journal: Journal of hematology & oncology
Published: February 04, 2024
Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma.
Journal: Journal of cancer research and clinical oncology
Published: May 04, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026